{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:28:43Z","timestamp":1770755323897,"version":"3.50.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medicine and Health Science and Technology plan projects in Zhejiang Province","award":["2022KY201"],"award-info":[{"award-number":["2022KY201"]}]},{"name":"Hebei Provincial Department of Science and Technology","award":["16397747D"],"award-info":[{"award-number":["16397747D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Brain invasion in meningiomas is considered an indicator of more aggressive behavior and worse prognosis. But the precise definition and the prognostic role of brain invasion remains unsolved duo to lacking a standardized workflow of surgical sampling and the histopathological detection. Searching for molecular biomarker expression correlating with brain invasion, could contribute to establish a molecular pathological diagnosis without problems of subjective interobserver variation and deeply understand the mechanism of brain invasion and develop innovative therapeutic strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We utilized liquid chromatography tandem mass spectrometry to quantify protein abundances between non-invasive meningiomas (n\u2009=\u200921) and brain-invasive meningiomas (n\u2009=\u200921) spanning World Health Organization grades I and III. After proteomic discrepancies were analyzed, the 14 most up-regulated or down-regulated proteins were recorded. Immunohistochemical staining for glial fibrillary acidic protein and most likely brain invasion-related proteins was performed in both groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 6498 unique proteins were identified in non-invasive and brain-invasive meningiomas. Canstatin expression in the non-invasive group was 2.1-fold that of the brain-invasive group. The immunohistochemical staining showed canstatin expressed in both groups, and the non-invasive group showed stronger staining for canstatin in the tumor mass (<jats:italic>p<\/jats:italic>\u2009=\u20090.0132) than the brain-invasive group, which showed moderate intensity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study demonstrated the low expression of canstatin in meningiomas with brain invasion, a finding that provide a basis for understanding the mechanism of brain invasion of meningiomas and may contribute to establish molecular pathological diagnosis and identify novel therapeutic targets for personalized care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11060-023-04256-z","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T07:02:56Z","timestamp":1677049376000},"page":"415-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Type IV collagen-derived angiogenesis inhibitor: canstatin low expressing in brain-invasive meningiomas using liquid chromatography\u2013mass spectrometry (LC-MS\/MS)"],"prefix":"10.1007","volume":"161","author":[{"given":"Jian","family":"Pei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun H.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao G.","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7439-7683","authenticated-orcid":false,"given":"Lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"4256_CR1","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/neuonc\/nox101","volume":"19","author":"M Nowosielski","year":"2017","unstructured":"Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M, Wick W, Sahm F (2017) Diagnostic challenges in meningioma. Neuro Oncol 19:1588\u20131598. https:\/\/doi.org\/10.1093\/neuonc\/nox101","journal-title":"Neuro Oncol"},{"key":"4256_CR2","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/neuonc\/nox071","volume":"19","author":"B Brokinkel","year":"2017","unstructured":"Brokinkel B, Hess K, Mawrin C (2017) Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review. Neuro Oncol 19:1298\u20131307. https:\/\/doi.org\/10.1093\/neuonc\/nox071","journal-title":"Neuro Oncol"},{"key":"4256_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1227\/NEU.0000000000000461","volume":"75","author":"SQ Sun","year":"2014","unstructured":"Sun SQ, Kim AH, Cai C, Murphy RK, DeWees T, Sylvester P, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR (2014) Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery 75:347\u2013354. https:\/\/doi.org\/10.1227\/NEU.0000000000000461. (discussion 354 \u2013 345; quiz 355)","journal-title":"Neurosurgery"},{"key":"4256_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1227\/NEU.0000000000000462","volume":"75","author":"SQ Sun","year":"2014","unstructured":"Sun SQ, Cai C, Murphy RK, DeWees T, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR, Kim AH (2014) Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery 75:356\u2013363. https:\/\/doi.org\/10.1227\/NEU.0000000000000462. (discussion 363)","journal-title":"Neurosurgery"},{"key":"4256_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/nan.12700","volume":"47","author":"R Banan","year":"2021","unstructured":"Banan R, Abbetmeier-Basse M, Hong B, Dumitru CA, Sahm F, Nakamura M, Krauss JK, Hartmann C (2021) The prognostic significance of clinicopathological features in meningiomas: microscopic brain invasion can predict patient outcome in otherwise benign meningiomas. Neuropathol Appl Neurobiol 47:724\u2013735. https:\/\/doi.org\/10.1111\/nan.12700","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4256_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-016-1598-1","volume":"132","author":"P Baumgarten","year":"2016","unstructured":"Baumgarten P, Gessler F, Schittenhelm J, Skardelly M, Tews DS, Senft C, Dunst M, Imoehl L, Plate KH, Wagner M, Steinbach JP, Seifert V, Mittelbronn M, Harter PN (2016) Brain invasion in otherwise benign meningiomas does not predict tumor recurrence. Acta Neuropathol 132:479\u2013481. https:\/\/doi.org\/10.1007\/s00401-016-1598-1","journal-title":"Acta Neuropathol"},{"key":"4256_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123620","author":"F Behling","year":"2020","unstructured":"Behling F, Fodi C, Gepfner-Tuma I, Machetanz K, Renovanz M, Skardelly M, Bornemann A, Honegger J, Tabatabai G, Tatagiba M, Schittenhelm J (2020) CNS invasion in meningioma-how the intraoperative assessment can improve the prognostic evaluation of tumor recurrence. Cancers. https:\/\/doi.org\/10.3390\/cancers12123620","journal-title":"Cancers"},{"key":"4256_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-019-03312-x","volume":"145","author":"A Biczok","year":"2019","unstructured":"Biczok A, Jungk C, Egensperger R, von Deimling A, Suchorska B, Tonn JC, Herold-Mende C, Schichor C (2019) Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome. J Neurooncol 145:469\u2013477. https:\/\/doi.org\/10.1007\/s11060-019-03312-x","journal-title":"J Neurooncol"},{"key":"4256_CR9","first-page":"7206","volume":"7","author":"T Backer-Grondahl","year":"2014","unstructured":"Backer-Grondahl T, Moen BH, Arnli MB, Torseth K, Torp SH (2014) Immunohistochemical characterization of brain-invasive meningiomas. Int J Clin Exp Pathol 7:7206\u20137219","journal-title":"Int J Clin Exp Pathol"},{"key":"4256_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.wneu.2016.06.055","volume":"93","author":"DC Spille","year":"2016","unstructured":"Spille DC, Hess K, Sauerland C, Sanai N, Stummer W, Paulus W, Brokinkel B (2016) Brain Invasion in meningiomas: incidence and correlations with clinical variables and prognosis. World Neurosurg 93:346\u2013354. https:\/\/doi.org\/10.1016\/j.wneu.2016.06.055","journal-title":"World Neurosurg"},{"key":"4256_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133259","author":"F Behling","year":"2021","unstructured":"Behling F, Hempel JM, Schittenhelm J (2021) Brain invasion in meningioma\u2014a prognostic potential worth exploring. Cancers. https:\/\/doi.org\/10.3390\/cancers13133259","journal-title":"Cancers"},{"key":"4256_CR12","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","volume":"21","author":"A Perry","year":"1997","unstructured":"Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455\u20131465. https:\/\/doi.org\/10.1097\/00000478-199712000-00008","journal-title":"Am J Surg Pathol"},{"key":"4256_CR13","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1007\/s00330-019-06197-6","volume":"29","author":"G Friconnet","year":"2019","unstructured":"Friconnet G, Espindola Ala VH, Janot K, Brinjikji W, Bogey C, Lemnos L, Salle H, Saleme S, Mounayer C, Rouchaud A (2019) MRI predictive score of pial vascularization of supratentorial intracranial meningioma. Eur Radiol 29:3516\u20133522. https:\/\/doi.org\/10.1007\/s00330-019-06197-6","journal-title":"Eur Radiol"},{"key":"4256_CR14","doi-asserted-by":"publisher","first-page":"i44","DOI":"10.1093\/neuonc\/noy143","volume":"21","author":"RY Huang","year":"2019","unstructured":"Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougere C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF, International Consortium on M (2019) Imaging and diagnostic advances for intracranial meningiomas. Neuro Oncol 21:i44\u2013i61. https:\/\/doi.org\/10.1093\/neuonc\/noy143","journal-title":"Neuro Oncol"},{"key":"4256_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1971400920953417","volume":"34","author":"T Ong","year":"2021","unstructured":"Ong T, Bharatha A, Alsufayan R, Das S, Lin AW (2021) MRI predictors for brain invasion in meningiomas. Neuroradiol J 34:3\u20137. https:\/\/doi.org\/10.1177\/1971400920953417","journal-title":"Neuroradiol J"},{"key":"4256_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/neuonc\/noaa190","volume":"23","author":"L Joo","year":"2021","unstructured":"Joo L, Park JE, Park SY, Nam SJ, Kim YH, Kim JH, Kim HS (2021) Extensive peritumoral edema and brain-to-tumor interface MRI features enable prediction of brain invasion in meningioma: development and validation. Neuro Oncol 23:324\u2013333. https:\/\/doi.org\/10.1093\/neuonc\/noaa190","journal-title":"Neuro Oncol"},{"key":"4256_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"4256_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"4256_CR19","doi-asserted-by":"publisher","DOI":"10.3171\/2019.3.JNS183411","author":"G Raffa","year":"2019","unstructured":"Raffa G, Picht T, Scibilia A, Rosler J, Rein J, Conti A, Ricciardo G, Cardali SM, Vajkoczy P, Germano A (2019) Surgical treatment of meningiomas located in the rolandic area: the role of navigated transcranial magnetic stimulation for preoperative planning, surgical strategy, and prediction of arachnoidal cleavage and motor outcome. J Neurosurg. https:\/\/doi.org\/10.3171\/2019.3.JNS183411","journal-title":"J Neurosurg"},{"key":"4256_CR20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.wneu.2016.08.047","volume":"95","author":"B Brokinkel","year":"2016","unstructured":"Brokinkel B, Stummer W (2016) Brain Invasion in meningiomas: the rising importance of a uniform neuropathologic assessment after the release of the 2016 world health organization classification of central nervous system tumors. World Neurosurg 95:614\u2013615. https:\/\/doi.org\/10.1016\/j.wneu.2016.08.047","journal-title":"World Neurosurg"},{"key":"4256_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.5414\/NP300750","volume":"33","author":"J Pizem","year":"2014","unstructured":"Pizem J, Velnar T, Prestor B, Mlakar J, Popovic M (2014) Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen. Clin Neuropathol 33:354\u2013363. https:\/\/doi.org\/10.5414\/NP300750","journal-title":"Clin Neuropathol"},{"key":"4256_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V, Mamatjan Y, Wang JZ, Hugh-White R, Macklin AM, Khan S, Singh O, Karimi S, Corona RI, Liu LY, Chen CY, Chakravarthy A, Wei Q, Mehani B, Suppiah S, Gao A, Workewych AM, Tabatabai G, Boutros PC, Bader GD, de Carvalho DD, Kislinger T, Aldape K, Zadeh G (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597:119\u2013125. https:\/\/doi.org\/10.1038\/s41586-021-03850-3","journal-title":"Nature"},{"key":"4256_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174163","author":"L Brunasso","year":"2022","unstructured":"Brunasso L, Bonosi L, Costanzo R, Buscemi F, Giammalva GR, Ferini G, Valenti V, Viola A, Umana GE, Gerardi RM, Sturiale CL, Albanese A, Iacopino DG, Maugeri R (2022) Updated systematic review on the role of brain invasion in intracranial meningiomas: what, when. Why? Cancers. https:\/\/doi.org\/10.3390\/cancers14174163","journal-title":"Cancers"},{"key":"4256_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s10014-021-00399-x","volume":"38","author":"C Qin","year":"2021","unstructured":"Qin C, Huang M, Pan Y, Li Y, Long W, Liu Q (2021) Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options. Brain Tumor Pathol 38:156\u2013172. https:\/\/doi.org\/10.1007\/s10014-021-00399-x","journal-title":"Brain Tumor Pathol"},{"key":"4256_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nrc1094","volume":"3","author":"R Kalluri","year":"2003","unstructured":"Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:422\u2013433. https:\/\/doi.org\/10.1038\/nrc1094","journal-title":"Nat Rev Cancer"},{"key":"4256_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0945-053x(95)90001-2","volume":"14","author":"K Kuhn","year":"1995","unstructured":"Kuhn K (1995) Basement membrane (type IV) collagen. Matrix Biol 14:439\u2013445. https:\/\/doi.org\/10.1016\/0945-053x(95)90001-2","journal-title":"Matrix Biol"},{"key":"4256_CR27","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","volume":"275","author":"GD Kamphaus","year":"2000","unstructured":"Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R (2000) Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275:1209\u20131215. https:\/\/doi.org\/10.1074\/jbc.275.2.1209","journal-title":"J Biol Chem"},{"key":"4256_CR28","doi-asserted-by":"publisher","first-page":"37632","DOI":"10.1074\/jbc.M307339200","volume":"278","author":"DJ Panka","year":"2003","unstructured":"Panka DJ, Mier JW (2003) Canstatin inhibits akt activation and induces Fas-dependent apoptosis in endothelial cells. J Biol Chem 278:37632\u201337636. https:\/\/doi.org\/10.1074\/jbc.M307339200","journal-title":"J Biol Chem"},{"key":"4256_CR29","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1158\/0008-5472.CAN-04-3536","volume":"65","author":"C Magnon","year":"2005","unstructured":"Magnon C, Galaup A, Mullan B, Rouffiac V, Bouquet C, Bidart JM, Griscelli F, Opolon P, Perricaudet M (2005) Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins. Cancer Res 65:4353\u20134361. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3536","journal-title":"Cancer Res"},{"key":"4256_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ctrv.2013.11.009","volume":"40","author":"G Limaverde-Sousa","year":"2014","unstructured":"Limaverde-Sousa G, Sternberg C, Ferreira CG (2014) Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents. Cancer Treat Rev 40:548\u2013557. https:\/\/doi.org\/10.1016\/j.ctrv.2013.11.009","journal-title":"Cancer Treat Rev"},{"key":"4256_CR31","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.bbagen.2013.12.029","volume":"1840","author":"JC Monboisse","year":"2014","unstructured":"Monboisse JC, Oudart JB, Ramont L, Brassart-Pasco S, Maquart FX (2014) Matrikines from basement membrane collagens: a new anti-cancer strategy. Biochim Biophys Acta 1840:2589\u20132598. https:\/\/doi.org\/10.1016\/j.bbagen.2013.12.029","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04256-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T09:17:44Z","timestamp":1678094264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04256-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["4256"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04256-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"31 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study protocol was approved by the ethics committee of TangShan GongRen Hospital (Ethical Number: GRYY-LL-2016-76).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}